Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection

Benjamin J Broomfield,Chin Wee Tan,Raymond Z Qin,Brigette C Duckworth,Carolina Alvarado,Lennard Dalit,Jinjin Chen,Liana Mackiewicz,Hiromi Muramatsu,Marc Pellegrini,Kelly Rogers,Woohyun J Moon,Stephen L Nutt,Melissa J Davis,Norbert Pardi,Verena Wimmer,Joanna R Groom
DOI: https://doi.org/10.1101/2024.06.26.600763
2024-06-28
Abstract:Developing vaccines that promote CD8+ T cell memory is a challenge for infectious disease and cancer immunotherapy. TCF-1+ stem cell-like memory T (TSCM) cells are important determinants of long-lived memory. Yet, the developmental requirements for TSCM formation are unclear. Here, we identify the temporal window for type I interferon (IFN-I) receptor (IFNAR) blockade to drive TSCM cell generation. TSCM cells were transcriptionally distinct and emerged from a transitional precursor of exhausted (TPEX) cellular state concomitant with viral clearance. TSCM differentiation correlated with T cell retention within the lymph node paracortex, due to increased CXCR3 chemokine abundance which disrupted gradient formation. These affects were due a counterintuitive increase in IFNγ, which controlled cell location. Combining IFNAR inhibition with mRNA-LNP vaccination promoted specific TSCM differentiation and enhanced protection against chronic infection. These finding propose a new approach to vaccine design whereby modulation of inflammation promotes memory formation and function.
Immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to enhance the stem - like memory (T SCM) differentiation of CD8+ T cells by briefly suppressing type I interferon (IFN - I) receptor (IFNAR), thereby improving the protection effect of vaccines. Specifically, the researchers explored whether briefly blocking IFNAR in the early stage of acute viral infection could promote the generation of T SCM cells without causing chronic infection. In addition, they also studied the impact of this intervention on T - cell migration and localization, and how to further enhance the protection effect by combining with mRNA - LNP vaccines. ### Main research contents: 1. **Brief suppression of IFNAR promotes T SCM cell differentiation**: - The study found that briefly suppressing IFNAR in the early stage of acute viral infection (day 0 and day 1 after infection) can significantly increase the generation of T SCM cells without causing chronic infection. - This brief IFNAR suppression enables T SCM cells to transition from a pre - exhausted state (T PEX), which occurs simultaneously with virus clearance. 2. **Differences in transcription and surface markers between T SCM and T PEX cells**: - Through single - cell RNA sequencing (scRNAseq) and CITEseq analysis, the researchers identified the transcriptional differences between T SCM and T PEX cells and discovered specific surface markers (such as CD61 and CD55) to distinguish these two cell states. - T SCM cells exhibit higher stem - cell characteristics, such as proliferation ability and long - term survival ability. 3. **The impact of IFNAR suppression on T - cell migration and localization**: - The study found that IFNAR suppression affects the retention of T cells in the paracortical area of lymph nodes by increasing the production of IFN - γ and regulating the expression of CXCR3 ligands. - This change in cell localization contributes to the formation and functional maintenance of T SCM cells. 4. **Combining mRNA - LNP vaccines to enhance protection effects**: - Combining IFNAR suppression and mRNA - LNP vaccination can further promote the generation of T SCM cells and improve the protection effect against chronic viral infection. - This finding provides a new strategy for vaccine design, that is, promoting the formation and function of memory T cells by regulating the inflammatory response. ### Key conclusions: - **Brief suppression of IFNAR**: Briefly suppressing IFNAR in the early stage of acute viral infection can promote the generation of T SCM cells without causing chronic infection. - **The generation path of T SCM cells**: T SCM cells transition from the T PEX cell state, and this process is synchronized with virus clearance. - **Cell migration and localization**: IFNAR suppression affects the localization of T cells in lymph nodes by regulating the expression of CXCR3 ligands, thereby promoting the formation of T SCM cells. - **New strategy for vaccine design**: Combining IFNAR suppression and mRNA - LNP vaccination can significantly improve the protection effect of vaccines, providing new ideas for vaccine design. These findings not only deepen the understanding of the generation mechanism of T SCM cells but also provide an important theoretical basis for the development of more effective vaccines and immunotherapies.